These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19300249)

  • 81. CROI 2019: neurologic complications of HIV disease.
    Ances BM; Letendre SL
    Top Antivir Med; 2019 Apr; 27(1):26-33. PubMed ID: 31137000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neurodevelopmental outcomes in children with HIV infection under 3 years of age.
    Foster CJ; Biggs RL; Melvin D; Walters MD; Tudor-Williams G; Lyall EG
    Dev Med Child Neurol; 2006 Aug; 48(8):677-82. PubMed ID: 16836781
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hope is forked: hope, loss, treatments, and AIDS dementia.
    Kelly A
    Qual Health Res; 2007 Sep; 17(7):866-72. PubMed ID: 17724098
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Progression of HIV-associated dementia treated with HAART.
    Dougherty RH; Skolasky RL; McArthur JC
    AIDS Read; 2002 Feb; 12(2):69-74. PubMed ID: 11905143
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Adjunctive therapies for HIV-1 associated neurologic disease.
    Perry SW; Norman JP; Gelbard HA
    Neurotox Res; 2005 Oct; 8(1-2):161-6. PubMed ID: 16260393
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
    Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553
    [TBL] [Abstract][Full Text] [Related]  

  • 89. HIV Infection Presenting with Dementia.
    Narayanan K; Gupta A; Manoj S; Seshadri K
    J Assoc Physicians India; 2015 Aug; 63(8):85-6. PubMed ID: 27604445
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
    Lipton SA
    Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical and biologic features of the AIDS dementia complex.
    Navia BA
    Neuroimaging Clin N Am; 1997 Aug; 7(3):581-92. PubMed ID: 9376969
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Central nervous system complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2011; 19(2):48-57. PubMed ID: 21868822
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy.
    Paul R
    Curr HIV/AIDS Rep; 2019 Jun; 16(3):230-235. PubMed ID: 31168712
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dramatic Improvement of MRI Abnormalities of HIV Encephalopathy after Suppressive Antiretroviral Therapy.
    Dietrich DK; Laidlaw E; Hammoud DA; Pau AK; Smith BR
    AIDS; 2023 Jul; 37(8):1339-1340. PubMed ID: 37771854
    [No Abstract]   [Full Text] [Related]  

  • 95. Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.
    Megra B; Eugenin E; Roberts T; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1159-66. PubMed ID: 23616272
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence.
    Putatunda R; Ho WZ; Hu W
    AIDS Rev; 2019; 21(1):11-22. PubMed ID: 30899112
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HIV and the neuropsychology of everyday life.
    Albert SM; Martin EM
    Neurology; 2014 Jun; 82(23):2046-7. PubMed ID: 24814850
    [No Abstract]   [Full Text] [Related]  

  • 98. Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.
    Ciborowski P
    Biomark Med; 2009 Dec; 3(6):771-85. PubMed ID: 20477714
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.
    Haughey NJ; Zhu X; Bandaru VV
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1136-46. PubMed ID: 24203462
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An Integrative Approach to the Current Treatment of HIV-Associated Neurocognitive Disorders and the Implementation of Leukemia Inhibitor Factor as a Mediator of Neurocognitive Preservation.
    De Freitas-Suarez A; Espinosa-Ponce N; Alvarez-Roger N; Cabrera-Suarez AI; Jiménez-Jordán G; Vega-Roman R; Inyushin M; Alves JM
    Life (Basel); 2023 Nov; 13(11):. PubMed ID: 38004334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.